Change description : 2025-09-26 13:47:00: Changes to the ‘Note on methadone/buprenorphine treatment programmes Group 1’ – revision of medical standard (Group 1 and Group 2)Changes to the High-risk offenders section to clarify licensing decision process. Alcohol dependence – the wording has been revised (but not revised the standard). [Guidance and regulation]
medication assisted alcohol withdrawal needed or required
The presence of one orthese more high-risk features is used to identify individuals with a physiological dependence on alcohol who are at an increased risk of relapse into dependant drinking.
Guidance on diagnosis of alcohol use disorders can be found in the Internal Classification of Diseases (11th revision) produced by the World Health Organisation, relevant codes 6C40.2 and 6C40.1, or the Diagnostic and Statistical Manual of Mental Disorder (DSM-5) for alcohol use disorder, relevant code FS10.20.
For both Group 1 (car(card or motorcycle) and Group 2 (lorry or bus):
licensing
*licensing may require satisfactory medical reports from a doctor
DVLA*DVLA may need to arrange independent medical examination and blood tests
Persistent alcohol misuse
Group 1 car and motorcycle
Group 2 bus and lorry
Persistent alcohol misuse including alcohol dependence without high-risk features, confirmed by medical enquiry and/or evidence of otherwise unexplained abnormal blood markers.
✘- Must not drive and must notify DVLA.
Licence will be refused or revoked until after:
■ a minimum of 6 months of controlled drinking or abstinence
✘- Must not drive and must notify DVLA.
Licence will be refused or revoked until after:
■ a minimum of 1 year of controlled drinking or abstinence
Definition of controlled drinking
Controlled drinking means drinking at a level and in a manner which their clinician confirms acceptably controls their alcohol use disorder and their alcohol use is unlikely to impact on personal, social, and work responsibilities.
Alcohol dependence
Guide to definition of dependence
Group 1 Car and motorcycle
Group 2 Bus and lorry
Dependence confirmed by medical enquiry with one or more high-risk features.
✘- Must not drive and must notify DVLA.
Licence will be refused or revoked until a minimum of 1 year’s abstinence from alcohol consumption has been attained.
Continued licensing will require ongoing abstinence for at least 3 years from the onset of abstinence which will be monitored by DVLA
✘- Must not drive and must notify DVLA.
Licence will be refused or revoked until a minimum of 3 years’ abstinence from alcohol consumption has been attained.
Continued licensing will require ongoing abstinence for at least 5 years from the onset of abstinence which will be monitored by DVLA
Alcohol-related disorders
Group 1 car and motorcycle
Group 2 bus and lorry
Examples
■ hepatic cirrhosis with chronic encephalopathy
■ alcohol induced psychosis
■ cognitive impairment
✘- Must not drive and must notify DVLA.
Licence will be refused or revoked until:
■ recovery is satisfactory ■ any other relevant medical standards for fitness to drive are satisfied (for example, Chapter 4, psychiatric disorders)
✘- Must not drive and must notify DVLA.
Licence will be refused or revoked until recovery is satisfactory.
Alcohol-related seizure
The relevant standards for any associated alcohol dependence should be applied.
Seizures associated with alcohol use may be considered provoked in terms of licensing (for details see neurological disorders and Appendix B).
Drug misuse or dependence
The relevant classification codes for drug misuse or dependence are World Health Organization F11 to F19 inclusive (ICD-10).
The below requirements apply to cases of single-substance misuse or dependence, whereas multiple problems – including with alcohol misuse or dependence – are not compatible with fitness to drive and licensing consideration, in both groups of drivers.
Group 1 Car and motorcycle
Group 2 Bus and lorry
Drug group ■ cannabis ■ amphetamines (but see methamphetamine drug group below) ■ ‘ecstasy’ (MDMA) ■ ketamine ■ other psychoactive substances, including LSD and hallucinogens
✘- Must not drive and must notify DVLA with persistent misuse or dependence.
Medical enquiry confirming the problem will result in licence being refused or revoked:
■ for a minimum of 6 months, which must be free of misuse or dependence
Relicensing may require an independent medical assessment and urine screen arranged by DVLA.
✘- Must not drive and must notify DVLA with persistent misuse or dependence.
Medical enquiry confirming the problem will result in licence being refused or revoked:
■ for a minimum of 1 year, which must be free of misuse or dependence
Relicensing will usually require an independent medical assessment and urine screen arranged by DVLA.
Group 1 Car and motorcycle
Group 2 Bus and lorry
Drug group ■ opiates (for example, heroin, morphine) ■ opioids (for example, codeine) ■ benzodiazepines ■ synthetic benzodiazepines ■ synthetic cannabinoids ■ methadone (note on compliance above) ■ cocaine ■ methamphetamine
Methadone/buprenorphine programmes - see guidelines below.
✘- Must not drive and must notify DVLA with persistent misuse or dependence.
Medical enquiry confirming the problem will result in licence being refused or revoked for a minimum of 1 year, which must be free of misuse or dependence.
Relicensing may require an independent medical assessment and urine screen arranged by DVLA.
✘- Must not drive and must notify DVLA with persistent misuse or dependence.
Medical enquiry confirming the problem will result in licence being refused or revoked for a minimum of 3 years, which must be free of misuse or dependence.
Relicensing will usually require an independent medical assessment and urine screen arranged by DVLA.
Note on methadone/buprenorphine treatment programmes
Group 1
Applicants or drivers complying fully with a methadoneconsultant or buprenorphineappropriatehealthcarepractitionersupervisedoralmethadonemaintenance programme may be licensed subject to favourable assessment and normally annual medical review. Applicantsordriversonanoralbuprenorphineprogrammemaybeconsideredapplyingthesamecriteria.There should be no evidence of continuing use of other substances including non-prescribed cannabis.
Application may be considered when all of the following conditions can be met:
stable on the programme for a minimum of 1 year
the treatment programme is forsupervised managementby ofa opiateconsultant dependenceor andspecialist managed according to GP
the guidancetreatment detailedis infor themanagement publication ‘Drugof misuseopiate and dependence. UK guidelines on clinical management’ (known as the ‘Orange Book’)dependence
oraloral/sublingual or sublingual treatment only (not parenteral) but subcutaneous long-acting buprenorphine or naltrexone implants may be considered
there has been compliance with the programme (adherence to prescription and appointments, and toxicology testing with sustained stability)
no non-prescribed psychoactive drug use during the programme or extra use of prescribed drugs such as methadone, buprenorphine, benzodiazepines
Applicants or drivers complying fully with a methadoneconsultant or buprenorphineappropriatehealthcarepractitionersupervisedoralmethadonemaintenance programme may be considered for an annual medical review licence, once a minimum 3-year period of stability on the maintenance programme has been established.establishedwithfavourablerandomurinetestsandassessment.Expertpaneladvicewillberequiredineachcase.
Application may be considered when all of the following conditions can be met:
stable on the programme for a minimum of 3 years
the treatment programme is forsupervised managementby ofa opiateconsultant dependenceor andspecialist managed according to GP
the guidancetreatment detailedis infor themanagement publicationof ‘Drugopiate misuse and dependence. UK guidelines on clinical management’ (known as the ‘Orange Book’)dependence
oraloral/sublingual or sublingual treatment only (not parenteral) but subcutaneous long-acting buprenorphine or naltrexone implants may be considered
there has been compliance with the programme (adherence to prescription and appointments, and toxicology testing with sustained stability)
no non-prescribed psychoactive drug use during the programme or extra use of prescribed drugs such as methadone, buprenorphine, benzodiazepines
Seizures associated with drug use may be considered provoked in terms of licensing (for details see neurological disorders and Appendix B).
In addition, the relevant standards for any associated drug misuse or dependence should be applied.
Relicensed drivers with former drug misuse or dependence should be advised as part of their aftercare that recurrence would mean they must stop driving and must notify DVLA.
High-risk offenders
The definition ‘high-risk offender’ applies to drivers convicted of the following:
one disqualification for driving or being in charge of a vehicle when the level of alcohol in the body equalled or exceeded either one of these measures:
87.5 mcg per 100 ml of breath
200.0 mg per 100 ml of blood
267.5 mg per 100 ml of urine
two disqualifications within the space of 10 years for drinking-driving or being in charge of a vehicle while under the influence of alcohol
one disqualification for refusing or failing to supply a specimen for alcohol analysis
one disqualification for refusing to give permission for a laboratory test of a specimen of blood for alcohol analysis
Defined in terms of the alcohol-related driving convictions above, the courts notify DVLA of drivers convicted of an offence.
An independent medical examination will be arranged when an application for licence reinstatement is received by DVLA. The assessment may include:
Introduction of a new standalone section for 'high risk offenders' to make the guidance itself clearer, and to relocate it from sitting in the 'alcohol-related seizure' section.
Minor amendments to the 'alcohol-related seizure' section to make clearer what standards should be applied.
Removal of minor duplication regarding benzodiazepines under 'drug misuse or dependence' section.
22 June 2022
Clarification of methadone/buprenorphine treatment programme standards
2 March 2021
Clarification of the alcohol dependence standards required both to regain and to retain both Group 1 and Group 2 licences.
Clarification that the standards for opioid misuse/dependence mirror those for opiate misuse/dependence.
The introduction of standards for the synthetic cannabinoids and synthetic benzodiazepines.
Addition of subcutaneous long acting buprenorphine to section covering methadone/buprenorphine treatment programmes.
26 September 2019
Guidance for ketamine misuse and dependence has been amended – both conditions now require 6 months off driving
14 February 2019
Update on guidance regarding methadone or buprenorphine treatment programmes.
31 August 2018
‘Controlled drinking’ defined.
1 January 2018
Clarification that all Group 1 requirements (including abstention, etc) also apply to Group 2 licensing.
22 June 2017
Minor updates.
7 March 2017
Content updated.
18 April 2016
Change to the information under alcohol dependence and alcohol-related seizure.